Advances in Targeted Therapies for Rehumatiod Arthritis: From Biologic to Small Molecule Inhibitors Article Swipe
Wasia Mansoor
,
Syed Moin Hassan
,
Aziz Ur Rahman
,
Anam Arshad
,
Waseem Safdar
,
Muhammad Mujtaba
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.70749/ijbr.v3i3.777
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.70749/ijbr.v3i3.777
This study aimed to evaluate the knowledge, practices, and perceptions of General Practitioners (GPs) in Punjab, Pakistan, regarding the treatment of rheumatoid arthritis (RA) with biologics and small molecule inhibitors, focusing on patient compliance, disease progression, and treatment outcomes. A total of 108 GPs participated, with data collected through self-administered questionnaires, which were analyzed using descriptive statistics, cross-tabulation, and inferential statistics such as chi-square tests and t-tests. The findings revealed that GPs exhibited good knowledge of biologics, with experienced GPs (11-20 years of practice) showing higher awareness compared to less experienced practitioners. The study also highlighted that oral small molecule inhibitors had higher patient compliance (80%) compared to injectable biologics (60%), likely due to the convenience of oral administration. Both treatments showed significant reductions in disease activity, with injectable biologics demonstrating a more substantial impact on disease progression. The results suggest that while both biologics and small molecule inhibitors are effective in managing RA, patient compliance and treatment convenience are critical factors influencing treatment outcomes. This study provides key insights into the effectiveness, safety, and patient compliance of biologics and small molecule inhibitors in rheumatoid arthritis treatment. Injectable biologics showed a stronger impact on disease progression, while oral inhibitors had higher patient compliance due to convenience. More experienced GPs demonstrated greater knowledge of biologic therapies, emphasizing the need for continuous education. The findings highlight the importance of improving treatment accessibility and ensuring that GPs, especially in underserved areas, receive adequate training for optimal RA management. Future research should focus on long-term outcomes, cost-effectiveness, and patient-centered treatment strategies in RA management.
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.70749/ijbr.v3i3.777
- OA Status
- hybrid
- Cited By
- 2
- References
- 55
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4408463579
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4408463579Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.70749/ijbr.v3i3.777Digital Object Identifier
- Title
-
Advances in Targeted Therapies for Rehumatiod Arthritis: From Biologic to Small Molecule InhibitorsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-03-12Full publication date if available
- Authors
-
Wasia Mansoor, Syed Moin Hassan, Aziz Ur Rahman, Anam Arshad, Waseem Safdar, Muhammad MujtabaList of authors in order
- Landing page
-
https://doi.org/10.70749/ijbr.v3i3.777Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.70749/ijbr.v3i3.777Direct OA link when available
- Concepts
-
Small molecule, Medicine, Arthritis, Computational biology, Biology, Immunology, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
2Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 2Per-year citation counts (last 5 years)
- References (count)
-
55Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4408463579 |
|---|---|
| doi | https://doi.org/10.70749/ijbr.v3i3.777 |
| ids.doi | https://doi.org/10.70749/ijbr.v3i3.777 |
| ids.openalex | https://openalex.org/W4408463579 |
| fwci | 4.41423655 |
| type | article |
| title | Advances in Targeted Therapies for Rehumatiod Arthritis: From Biologic to Small Molecule Inhibitors |
| biblio.issue | 3 |
| biblio.volume | 3 |
| biblio.last_page | 88 |
| biblio.first_page | 76 |
| topics[0].id | https://openalex.org/T11440 |
| topics[0].field.id | https://openalex.org/fields/16 |
| topics[0].field.display_name | Chemistry |
| topics[0].score | 0.9968000054359436 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1605 |
| topics[0].subfield.display_name | Organic Chemistry |
| topics[0].display_name | Click Chemistry and Applications |
| topics[1].id | https://openalex.org/T10274 |
| topics[1].field.id | https://openalex.org/fields/16 |
| topics[1].field.display_name | Chemistry |
| topics[1].score | 0.9958000183105469 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1605 |
| topics[1].subfield.display_name | Organic Chemistry |
| topics[1].display_name | Synthesis and biological activity |
| topics[2].id | https://openalex.org/T10200 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9944999814033508 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2745 |
| topics[2].subfield.display_name | Rheumatology |
| topics[2].display_name | Rheumatoid Arthritis Research and Therapies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C161624437 |
| concepts[0].level | 2 |
| concepts[0].score | 0.5117990374565125 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1988322 |
| concepts[0].display_name | Small molecule |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5016300678253174 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2777077863 |
| concepts[2].level | 2 |
| concepts[2].score | 0.43383553624153137 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q170990 |
| concepts[2].display_name | Arthritis |
| concepts[3].id | https://openalex.org/C70721500 |
| concepts[3].level | 1 |
| concepts[3].score | 0.3264337182044983 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[3].display_name | Computational biology |
| concepts[4].id | https://openalex.org/C86803240 |
| concepts[4].level | 0 |
| concepts[4].score | 0.2063448429107666 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[4].display_name | Biology |
| concepts[5].id | https://openalex.org/C203014093 |
| concepts[5].level | 1 |
| concepts[5].score | 0.18254587054252625 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[5].display_name | Immunology |
| concepts[6].id | https://openalex.org/C54355233 |
| concepts[6].level | 1 |
| concepts[6].score | 0.09535947442054749 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[6].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/small-molecule |
| keywords[0].score | 0.5117990374565125 |
| keywords[0].display_name | Small molecule |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.5016300678253174 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/arthritis |
| keywords[2].score | 0.43383553624153137 |
| keywords[2].display_name | Arthritis |
| keywords[3].id | https://openalex.org/keywords/computational-biology |
| keywords[3].score | 0.3264337182044983 |
| keywords[3].display_name | Computational biology |
| keywords[4].id | https://openalex.org/keywords/biology |
| keywords[4].score | 0.2063448429107666 |
| keywords[4].display_name | Biology |
| keywords[5].id | https://openalex.org/keywords/immunology |
| keywords[5].score | 0.18254587054252625 |
| keywords[5].display_name | Immunology |
| keywords[6].id | https://openalex.org/keywords/genetics |
| keywords[6].score | 0.09535947442054749 |
| keywords[6].display_name | Genetics |
| language | en |
| locations[0].id | doi:10.70749/ijbr.v3i3.777 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4404663325 |
| locations[0].source.issn | 2960-2793, 2960-2807 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2960-2793 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Indus journal of bioscience research. |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].source.host_organization_lineage | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Indus Journal of Bioscience Research |
| locations[0].landing_page_url | https://doi.org/10.70749/ijbr.v3i3.777 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5116629205 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Wasia Mansoor |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | None Wasia Mansoor |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5081645171 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-1544-3280 |
| authorships[1].author.display_name | Syed Moin Hassan |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | None Syed Muhammad Zain Ul Hassan |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5087210147 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-5014-7903 |
| authorships[2].author.display_name | Aziz Ur Rahman |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | None Aziz ur Rahman |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5051961578 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0418-8955 |
| authorships[3].author.display_name | Anam Arshad |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | None Anam Arshad |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5062002754 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3350-4112 |
| authorships[4].author.display_name | Waseem Safdar |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | None Syeda Hira Waseem |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5074181568 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8392-9226 |
| authorships[5].author.display_name | Muhammad Mujtaba |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | None Muhammad Mujtaba |
| authorships[5].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.70749/ijbr.v3i3.777 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Advances in Targeted Therapies for Rehumatiod Arthritis: From Biologic to Small Molecule Inhibitors |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11440 |
| primary_topic.field.id | https://openalex.org/fields/16 |
| primary_topic.field.display_name | Chemistry |
| primary_topic.score | 0.9968000054359436 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1605 |
| primary_topic.subfield.display_name | Organic Chemistry |
| primary_topic.display_name | Click Chemistry and Applications |
| related_works | https://openalex.org/W2899084033, https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 2 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 2 |
| locations_count | 1 |
| best_oa_location.id | doi:10.70749/ijbr.v3i3.777 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4404663325 |
| best_oa_location.source.issn | 2960-2793, 2960-2807 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2960-2793 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Indus journal of bioscience research. |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.source.host_organization_lineage | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Indus Journal of Bioscience Research |
| best_oa_location.landing_page_url | https://doi.org/10.70749/ijbr.v3i3.777 |
| primary_location.id | doi:10.70749/ijbr.v3i3.777 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4404663325 |
| primary_location.source.issn | 2960-2793, 2960-2807 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2960-2793 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Indus journal of bioscience research. |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.source.host_organization_lineage | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Indus Journal of Bioscience Research |
| primary_location.landing_page_url | https://doi.org/10.70749/ijbr.v3i3.777 |
| publication_date | 2025-03-12 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2068359337, https://openalex.org/W2149026148, https://openalex.org/W4281556265, https://openalex.org/W3181834541, https://openalex.org/W1905136944, https://openalex.org/W4321166025, https://openalex.org/W2904023906, https://openalex.org/W2622000437, https://openalex.org/W2092099033, https://openalex.org/W4407845410, https://openalex.org/W2545273878, https://openalex.org/W4406881384, https://openalex.org/W2101558198, https://openalex.org/W2016950635, https://openalex.org/W2011520765, https://openalex.org/W2803973097, https://openalex.org/W3039530223, https://openalex.org/W2141436693, https://openalex.org/W2338269660, https://openalex.org/W3112519253, https://openalex.org/W2073791328, https://openalex.org/W2146113881, https://openalex.org/W2060069128, https://openalex.org/W2786492839, https://openalex.org/W1209106218, https://openalex.org/W2041944580, https://openalex.org/W3189949217, https://openalex.org/W1973232910, https://openalex.org/W1946521533, https://openalex.org/W2168694883, https://openalex.org/W2069973593, https://openalex.org/W2895590824, https://openalex.org/W1978953318, https://openalex.org/W3085095620, https://openalex.org/W2803975545, https://openalex.org/W2928707605, https://openalex.org/W2867061072, https://openalex.org/W2114633137, https://openalex.org/W2134061119, https://openalex.org/W2413887177, https://openalex.org/W2916926950, https://openalex.org/W3161432498, https://openalex.org/W2115162045, https://openalex.org/W2270670296, https://openalex.org/W626649172, https://openalex.org/W2418942914, https://openalex.org/W2021255160, https://openalex.org/W1989560280, https://openalex.org/W2164306001, https://openalex.org/W2766460886, https://openalex.org/W2767394258, https://openalex.org/W2000468514, https://openalex.org/W2527933857, https://openalex.org/W3022414345, https://openalex.org/W2612729795 |
| referenced_works_count | 55 |
| abstract_inverted_index.A | 39 |
| abstract_inverted_index.a | 131, 190 |
| abstract_inverted_index.RA | 243, 258 |
| abstract_inverted_index.as | 62 |
| abstract_inverted_index.in | 14, 124, 151, 183, 235, 257 |
| abstract_inverted_index.of | 10, 20, 41, 75, 82, 116, 177, 212, 226 |
| abstract_inverted_index.on | 31, 135, 193, 249 |
| abstract_inverted_index.to | 3, 88, 107, 113, 204 |
| abstract_inverted_index.108 | 42 |
| abstract_inverted_index.GPs | 43, 71, 79, 208 |
| abstract_inverted_index.RA, | 153 |
| abstract_inverted_index.The | 67, 92, 138, 221 |
| abstract_inverted_index.and | 8, 26, 36, 58, 65, 145, 156, 174, 179, 230, 253 |
| abstract_inverted_index.are | 149, 159 |
| abstract_inverted_index.due | 112, 203 |
| abstract_inverted_index.for | 218, 241 |
| abstract_inverted_index.had | 101, 199 |
| abstract_inverted_index.key | 168 |
| abstract_inverted_index.the | 5, 18, 114, 171, 216, 224 |
| abstract_inverted_index.(RA) | 23 |
| abstract_inverted_index.Both | 119 |
| abstract_inverted_index.GPs, | 233 |
| abstract_inverted_index.More | 206 |
| abstract_inverted_index.This | 0, 165 |
| abstract_inverted_index.also | 94 |
| abstract_inverted_index.both | 143 |
| abstract_inverted_index.data | 46 |
| abstract_inverted_index.good | 73 |
| abstract_inverted_index.into | 170 |
| abstract_inverted_index.less | 89 |
| abstract_inverted_index.more | 132 |
| abstract_inverted_index.need | 217 |
| abstract_inverted_index.oral | 97, 117, 197 |
| abstract_inverted_index.such | 61 |
| abstract_inverted_index.that | 70, 96, 141, 232 |
| abstract_inverted_index.were | 52 |
| abstract_inverted_index.with | 24, 45, 77, 127 |
| abstract_inverted_index.(80%) | 105 |
| abstract_inverted_index.(GPs) | 13 |
| abstract_inverted_index.aimed | 2 |
| abstract_inverted_index.focus | 248 |
| abstract_inverted_index.small | 27, 98, 146, 180 |
| abstract_inverted_index.study | 1, 93, 166 |
| abstract_inverted_index.tests | 64 |
| abstract_inverted_index.total | 40 |
| abstract_inverted_index.using | 54 |
| abstract_inverted_index.which | 51 |
| abstract_inverted_index.while | 142, 196 |
| abstract_inverted_index.years | 81 |
| abstract_inverted_index.(11-20 | 80 |
| abstract_inverted_index.(60%), | 110 |
| abstract_inverted_index.Future | 245 |
| abstract_inverted_index.areas, | 237 |
| abstract_inverted_index.higher | 85, 102, 200 |
| abstract_inverted_index.impact | 134, 192 |
| abstract_inverted_index.likely | 111 |
| abstract_inverted_index.should | 247 |
| abstract_inverted_index.showed | 121, 189 |
| abstract_inverted_index.General | 11 |
| abstract_inverted_index.Punjab, | 15 |
| abstract_inverted_index.disease | 34, 125, 136, 194 |
| abstract_inverted_index.factors | 161 |
| abstract_inverted_index.greater | 210 |
| abstract_inverted_index.optimal | 242 |
| abstract_inverted_index.patient | 32, 103, 154, 175, 201 |
| abstract_inverted_index.receive | 238 |
| abstract_inverted_index.results | 139 |
| abstract_inverted_index.safety, | 173 |
| abstract_inverted_index.showing | 84 |
| abstract_inverted_index.suggest | 140 |
| abstract_inverted_index.through | 48 |
| abstract_inverted_index.adequate | 239 |
| abstract_inverted_index.analyzed | 53 |
| abstract_inverted_index.biologic | 213 |
| abstract_inverted_index.compared | 87, 106 |
| abstract_inverted_index.critical | 160 |
| abstract_inverted_index.ensuring | 231 |
| abstract_inverted_index.evaluate | 4 |
| abstract_inverted_index.findings | 68, 222 |
| abstract_inverted_index.focusing | 30 |
| abstract_inverted_index.insights | 169 |
| abstract_inverted_index.managing | 152 |
| abstract_inverted_index.molecule | 28, 99, 147, 181 |
| abstract_inverted_index.provides | 167 |
| abstract_inverted_index.research | 246 |
| abstract_inverted_index.revealed | 69 |
| abstract_inverted_index.stronger | 191 |
| abstract_inverted_index.t-tests. | 66 |
| abstract_inverted_index.training | 240 |
| abstract_inverted_index.Pakistan, | 16 |
| abstract_inverted_index.activity, | 126 |
| abstract_inverted_index.arthritis | 22, 185 |
| abstract_inverted_index.awareness | 86 |
| abstract_inverted_index.biologics | 25, 109, 129, 144, 178, 188 |
| abstract_inverted_index.collected | 47 |
| abstract_inverted_index.effective | 150 |
| abstract_inverted_index.exhibited | 72 |
| abstract_inverted_index.highlight | 223 |
| abstract_inverted_index.improving | 227 |
| abstract_inverted_index.knowledge | 74, 211 |
| abstract_inverted_index.long-term | 250 |
| abstract_inverted_index.outcomes, | 251 |
| abstract_inverted_index.outcomes. | 38, 164 |
| abstract_inverted_index.practice) | 83 |
| abstract_inverted_index.regarding | 17 |
| abstract_inverted_index.treatment | 19, 37, 157, 163, 228, 255 |
| abstract_inverted_index.Injectable | 187 |
| abstract_inverted_index.biologics, | 76 |
| abstract_inverted_index.chi-square | 63 |
| abstract_inverted_index.compliance | 104, 155, 176, 202 |
| abstract_inverted_index.continuous | 219 |
| abstract_inverted_index.education. | 220 |
| abstract_inverted_index.especially | 234 |
| abstract_inverted_index.importance | 225 |
| abstract_inverted_index.inhibitors | 100, 148, 182, 198 |
| abstract_inverted_index.injectable | 108, 128 |
| abstract_inverted_index.knowledge, | 6 |
| abstract_inverted_index.practices, | 7 |
| abstract_inverted_index.reductions | 123 |
| abstract_inverted_index.rheumatoid | 21, 184 |
| abstract_inverted_index.statistics | 60 |
| abstract_inverted_index.strategies | 256 |
| abstract_inverted_index.therapies, | 214 |
| abstract_inverted_index.treatment. | 186 |
| abstract_inverted_index.treatments | 120 |
| abstract_inverted_index.compliance, | 33 |
| abstract_inverted_index.convenience | 115, 158 |
| abstract_inverted_index.descriptive | 55 |
| abstract_inverted_index.emphasizing | 215 |
| abstract_inverted_index.experienced | 78, 90, 207 |
| abstract_inverted_index.highlighted | 95 |
| abstract_inverted_index.inferential | 59 |
| abstract_inverted_index.influencing | 162 |
| abstract_inverted_index.inhibitors, | 29 |
| abstract_inverted_index.management. | 244, 259 |
| abstract_inverted_index.perceptions | 9 |
| abstract_inverted_index.significant | 122 |
| abstract_inverted_index.statistics, | 56 |
| abstract_inverted_index.substantial | 133 |
| abstract_inverted_index.underserved | 236 |
| abstract_inverted_index.convenience. | 205 |
| abstract_inverted_index.demonstrated | 209 |
| abstract_inverted_index.progression, | 35, 195 |
| abstract_inverted_index.progression. | 137 |
| abstract_inverted_index.Practitioners | 12 |
| abstract_inverted_index.accessibility | 229 |
| abstract_inverted_index.demonstrating | 130 |
| abstract_inverted_index.participated, | 44 |
| abstract_inverted_index.effectiveness, | 172 |
| abstract_inverted_index.practitioners. | 91 |
| abstract_inverted_index.administration. | 118 |
| abstract_inverted_index.questionnaires, | 50 |
| abstract_inverted_index.patient-centered | 254 |
| abstract_inverted_index.cross-tabulation, | 57 |
| abstract_inverted_index.self-administered | 49 |
| abstract_inverted_index.cost-effectiveness, | 252 |
| cited_by_percentile_year.max | 97 |
| cited_by_percentile_year.min | 95 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile.value | 0.88975495 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |